Royce & Associates’s EnteroMedics Inc. ETRM Stock Holding History

Royce & Associates’s Portfolio ETRM Stock Details ETRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-618	Closed	-$798K	–	1463
2014 Q3	$798K	Sell	618 -392	-39%	-$575K	﹤0.01%	1157
2014 Q2	$1.65M	Sell	1,010 -214	-17%	-$400K	﹤0.01%	1072
2014 Q1	$2.34M	Hold	1,224	–	–	0.01%	1025
2013 Q4	$2.62M	Buy	1,224 +1,191	+3,609%	+$1.92M	0.01%	1018
2013 Q3	$44K	Sell	33 -15	-31%	-$17.5K	﹤0.01%	1407
2013 Q2	$57K	Buy	+48	New	+$50.7K	﹤0.01%	1372

Other funds holding ETRM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return

Royce & Associates's ETRM Position: Q4 2014 in Review

Royce & Associates sold out of EnteroMedics Inc. (ETRM) in Q4 2014, closing a stake of 618 shares — an estimated $798K sold.

Royce & Associates first reported a position in ETRM in Q2 2013 and held it in 6 quarters. The position peaked at $2.62M in Q4 2013. 46 funds tracked by Wall St. Rank hold ETRM as of Q4 2014.

Royce & Associates reported no remaining EnteroMedics Inc. position as of Q4 2014 after selling out during the quarter.
Royce & Associates sold 618 EnteroMedics Inc. shares in Q4 2014, an estimated $798K.
Royce & Associates first reported a position in EnteroMedics Inc. in Q2 2013 and held it in 6 quarters.
Royce & Associates's EnteroMedics Inc. position peaked at $2.62M in Q4 2013.
46 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2014.

Based on Royce & Associates's 13F filing for Q4 2014, filed 9 Feb 2015.